Sigyn Therapeutics, Inc.
SIGY· OTC
Filed Mar 30, 2016 · 10-K · 90 days after period end · 0001615774-16-004714
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$1.24M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end